These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10633831)

  • 1. Trends in inflammatory bowel disease therapy.
    Thomson AB; Williams CN
    Can J Gastroenterol; 1999 Nov; 13(9):775-6. PubMed ID: 10633831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic inflammatory bowel diseases. Proven and innovative in the treatment].
    MMW Fortschr Med; 2006 Jun; 148(24):43. PubMed ID: 16850809
    [No Abstract]   [Full Text] [Related]  

  • 3. Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.
    Di Cesare A; Fidanza R; Riitano A; Fargnoli MC; Peris K
    Eur J Dermatol; 2011; 21(5):784-5. PubMed ID: 21697068
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical treatment of inflammatory bowel disease.
    Singhal A; Kar P
    J Assoc Physicians India; 1995 Sep; 43(9):627-31. PubMed ID: 8773067
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inflammatory diseases of the intestines].
    Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
    Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease].
    Marteau P; Seksik P
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C94-7. PubMed ID: 11787388
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammatory bowel disease.
    Podolsky DK
    N Engl J Med; 2002 Aug; 347(6):417-29. PubMed ID: 12167685
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR
    CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Probiotics in chronic inflammatory bowel disease].
    Böhm S; Kruis W
    MMW Fortschr Med; 2006 Aug; 148(35-36):30-4. PubMed ID: 16995360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease: an update on the fundamental biology and clinical management.
    Blumberg R; Cho J; Lewis J; Wu G
    Gastroenterology; 2011 May; 140(6):1701-3. PubMed ID: 21530735
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications for immunosuppressive therapy of chronic inflammatory bowel diseases].
    Schölmerich J
    Internist (Berl); 1997 Jun; 38(6):582-9. PubMed ID: 9265003
    [No Abstract]   [Full Text] [Related]  

  • 15. Mea culpa.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):409. PubMed ID: 18670441
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathophysiology of inflammatory bowel diseases and the therapeutic strategy].
    Hibi T; Ogata H
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):499-504. PubMed ID: 15052810
    [No Abstract]   [Full Text] [Related]  

  • 17. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in therapy of inflammatory bowel diseases].
    Kougo Y
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1755-8. PubMed ID: 10581759
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.
    Gisbert JP; Gomollón F; Maté J; Pajares JM
    Dig Dis Sci; 2002 Mar; 47(3):471-88. PubMed ID: 11911332
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammatory bowel disease: short- and long-term treatments.
    Bickston SJ; Cominelli F
    Dis Mon; 1998 Apr; 44(4):144-72. PubMed ID: 9580743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.